We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Fintel reports that on October 17, 2024, Bernstein initiated coverage of Moderna (NasdaqGS:MRNA) with a Market Perform ...

The pharma’s lawsuit focuses on scientific work that helped clear the path for creating mRNA vaccines to fight the COVID-19 ...

The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it ...

智通财经APP获悉，周三，美国西北大学 (Northwestern University)在特拉华州联邦法院对Moderna (MRNA.US)提起了一项新的专利诉讼，指控该公司滥用该校的创新成果来开发其重磅的新冠疫苗Spikevax。

Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK ...

Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle ...

作者：黄莺俗话说人红是非多。在新冠疫情期间，凭借mRNA疫苗大获成功的Moderna公司，从年营收只有几千万美元的公司，一举跨入年营收200亿美元的公司行列。而这为其也带来了越来越多的专利纠纷。2021年，Moderna与美国国立卫生研究院的mRNA ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $54.82 which represents a decrease of $-2.64 or -4.59% from the prior close of $57.46. The stock opened at $57.08 and touched a ...